Retatrutide Safety Profile Nausea: 16-25% (dose-dependent) Diarrhea: 16-22% Heart rate increase at higher doses Discontinuation: 6-10% Limited long-term safety data Tirzepatide Safety Profile Nausea: 12-24% (dose-dependent) Diarrhea: 12-18% No significant heart rate changes Discontinuation: 5-7% Extensive Phase 3 and real-world data GI side effects were broadly similar between the two compounds in their respective trials, though direct comparison is limited by different study designs
My Experience With Tirzepatide Tirzepatide was more tolerable for me
Research shows this dual incretin action can significantly reduce appetite, enhance satiety, and lower caloric intake, making retatrutide a strong focus in weight-management and obesity research
Medications can help, but healthy habits do the heavy lifting in the long run, Defnet notes
(Raphal Mazoyer, Finnricks COO, cautions that customers should always verify Certificates of Analysis with the companies that issued them and check they include a batch identifier.) Compound Sciences sells 20 mg of retatrutide (branded as GLP3 RT-20) for $79.99
Can J Physiol Pharmacol